World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
49
Citations
8584
World Ranking
14821
National Ranking
524

Antonio Lavecchia publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Antonio Lavecchia sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 190 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Antonio Lavecchia D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Antonio Lavecchia sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 49 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Antonio Lavecchia is affiliated with the University of Naples Federico II in Italy. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, with a significant focus on Medicine as well. Within these broader areas, their work concentrates on several subfields including Molecular Biology, Computational Theory and Mathematics, Physiology, Materials Chemistry, and Organic Chemistry.

The scientist's research topics are diverse, prominently featuring Computational Drug Discovery Methods, Peroxisome Proliferator-Activated Receptors, and Machine Learning in Materials Science. Other areas of focus include Genetics, Bioinformatics, and Biomedical Research, Eicosanoids and Hypertension Pharmacology, Microbial Natural Products and Biosynthesis, as well as Protein Structure and Dynamics.

Antonio Lavecchia has contributed to multiple research papers, some of which are listed below with their publication year and venue:

  • Unleashing the power of generative AI in drug discovery, 2024, Drug Discovery Today
  • New avenues in artificial-intelligence-assisted drug discovery, 2023, Drug Discovery Today
  • Artificial Intelligence in Natural Product Drug Discovery: Current Applications and Future Perspectives, 2025, Journal of Medicinal Chemistry
  • Current status and future prospects of molecular hybrids with thiazolidinedione (TZD) scaffold in anticancer drug discovery, 2021, Journal of Molecular Structure
  • Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy, 2020, Bioorganic Chemistry

The scientist frequently publishes in several notable venues, with a notable number of contributions in:

  • Drug Discovery Today
  • European Journal of Medicinal Chemistry
  • Journal of Medicinal Chemistry
  • International Journal of Molecular Sciences
  • Journal of Chemical Information and Modeling

Antonio Lavecchia collaborates with various co-authors in their research. Frequent collaborators include:

  • Carmen Cerchia
  • Fulvio Loiodice
  • Antonio Laghezza
  • Amit Gangwal
  • C. S. Ramaa

Best Publications

  • Machine-learning approaches in drug discovery: methods and applications.

    Antonio Lavecchia

  • Virtual screening strategies in drug discovery: a critical review.

    A Lavecchia;C Di Giovanni

  • Deep learning in drug discovery: opportunities, challenges and future prospects

    Antonio Lavecchia

  • In silico methods to address polypharmacology: current status, applications and future perspectives.

    Antonio Lavecchia;Carmen Cerchia

  • Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies

    Giuseppe La Regina;Michael C. Edler;Andrea Brancale;Sahar Kandil

  • Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide.

    Rino Ragno;Antonio Coluccia;Giuseppe La Regina;Gabriella De Martino

  • Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity.

    Concettina La Motta;Stefania Sartini;Laura Mugnaini;Francesca Simorini

  • Docking studies on αvβ3 integrin ligands: Pharmacophore refinement and implications for drug design

    Luciana Marinelli;Antonio Lavecchia;Kay-E. Gottschalk;Ettore Novellino

  • Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands.

    Giorgio Pochetti;Cristina Godio;Nico Mitro;Donatella Caruso

  • New Pyrrole Inhibitors of Monoamine Oxidase: Synthesis, Biological Evaluation, and Structural Determinants of MAO-A and MAO-B Selectivity

    Giuseppe La Regina;Romano Silvestri;Marino Artico;Antonio Lavecchia

  • Crystal Structure of the Peroxisome Proliferator-Activated Receptor gamma (PPARgamma) Ligand Binding Domain Complexed with a Novel Partial Agonist: A New Region of the Hydrophobic Pocket Could Be Exploited for Drug Design

    Roberta Montanari;Fulvio Saccoccia;Elena Scotti;Maurizio Crestani

  • Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.

    Roberto Di Santo;Roberta Costi;Alessandra Roux;Marino Artico

  • Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculations.

    Sandro Cosconati;Luciana Marinelli;and Antonio Lavecchia;Ettore Novellino

  • Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.

    Paola Vitale;Stefania Tacconelli;Maria Grazia Perrone;Paola Malerba

  • Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors

    Paolo Grieco;Antonio Lavecchia;Minying Cai;Devendra Trivedi

  • Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode.

    Davide Capelli;Carmen Cerchia;Roberta Montanari;Fulvio Loiodice

  • Ligand Binding Analysis for Human α5β1 Integrin: Strategies for Designing New α5β1 Integrin Antagonists

    Luciana Marinelli;Axel Meyer;Dominik Heckmann;Antonio Lavecchia

  • Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.

    Adele Bolognese;Gaetano Correale;Michele Manfra;Antonio Lavecchia

  • Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability.

    Giuseppe La Regina;Ruoli Bai;Willeke Rensen;Antonio Coluccia

  • New avenues in artificial-intelligence-assisted drug discovery

    Unknown

  • STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment

    A. Lavecchia;C. Di Giovanni;E. Novellino

  • Synthesis, Cannabinoid Receptor Affinity, and Molecular Modeling Studies of Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides

    Romano Silvestri;Maria Grazia Cascio;Giuseppe La Regina;Francesco Piscitelli

  • CDC25 phosphatase inhibitors: an update.

    A. Lavecchia;C. Di Giovanni;E. Novellino

  • Modeling of Cdc25B dual specifity protein phosphatase inhibitors: docking of ligands and enzymatic inhibition mechanism.

    Antonio Lavecchia;Sandro Cosconati;Vittorio Limongelli;Ettore Novellino

  • Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review.

    Antonio Lavecchia;Carmen Di Giovanni;Ettore Novellino

Frequent Co-Authors

Ettore Novellino
Ettore Novellino University of Naples Federico II
Claudia Martini
Claudia Martini University of Pisa
Federico Da Settimo
Federico Da Settimo University of Pisa
Karl-Norbert Klotz
Karl-Norbert Klotz University of Würzburg
Romano Silvestri
Romano Silvestri Sapienza University of Rome
Marino Artico
Marino Artico Sapienza University of Rome
Nico Mitro
Nico Mitro University of Milan
Livio Luongo
Livio Luongo University of Campania "Luigi Vanvitelli"
Sabatino Maione
Sabatino Maione University of Campania "Luigi Vanvitelli"
Paolo La Colla
Paolo La Colla University of Cagliari

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Chemistry can open diverse career opportunities. For instance, those interested in law enforcement or forensic chemistry might consider programs like criminal justice degrees. Understanding the criminal justice degree online cost is essential when planning your education path, as tuition and fees can vary widely.

If you're looking for a shorter, focused entry point, the best online associates in criminal justice provide foundational knowledge and practical skills, often available at a lower cost and with flexible schedules.

For those combining chemistry expertise with legal support roles, pursuing a paralegal certificate can enhance job prospects in regulatory compliance, patent law, or environmental law sectors.

Alternatively, a career as a pharmaceutical sales representative may suit chemistry graduates interested in the business side of science. Researching the pharmaceutical sales rep salary and career paths helps set realistic expectations for this dynamic role.

Best Scientists Citing Antonio Lavecchia

Trending Scientists

Recently Published Articles